Commentary
Video
Factoring in Trastuzumab Deruxtecan in the Advanced BTC Setting
Author(s):
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss how to factor in trastuzumab deruxtecan in advanced biliary tract cancer.
EP: 1.Prognosis and Standards of Care in Advanced Biliary Tract Cancer
EP: 2.Discussion of a Patient Case of Advanced BTC
EP: 3.Homing in on the TOPAZ-1 Trial in Biliary Tract Cancer
EP: 4.Putting TOPAZ-1 Data into Context for Patients With Advanced BTC
EP: 5.Clinical Implications of 3-Year OS Data With Durvalumab/Chemo in Advanced BTC
EP: 6.Considering Factors When Choosing Among IO Agents in Advanced BTC
Now Viewing
EP: 7.Factoring in Trastuzumab Deruxtecan in the Advanced BTC Setting
EP: 8.The Investigational Pipeline for Advanced BTC
Related Videos
Related Content
